Abstract
• CO-RADS improves the risk classification by 65.8% in patients affected by COVID-19. • CO-RADS combined with RT-PCR presents an AUC of 0.98 for patients with COVID-19. • CO-RADS improves the risk classification by 82.1% in patients not affected by COVID-19.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.